Get my own profile
Public access
View all68 articles
15 articles
available
not available
Based on funding mandates
Co-authors
- Huw ThomasSenior Research AssociateVerified email at ncl.ac.uk
- Ian Robert HardcastleNewcastle UniversityVerified email at ncl.ac.uk
- Martin NobleProfessor of Structural Biology and Anticancer Drug DesignVerified email at ncl.ac.uk
- Jane EndicottProfessor of Cancer Structural Biology, Newcastle UniversityVerified email at ncl.ac.uk
- Thomas HelledayKarolinska InstitutetVerified email at ki.se
- Philip JewsburyAstraZeneca PharmaceuticalsVerified email at wasabi1.plus.com
- Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityVerified email at oncology.ox.ac.uk
- Celine CanoNewcastle universityVerified email at ncl.ac.uk
- Deborah A. TweddleProfessor of Paediatric Oncology, Newcastle UniversityVerified email at newcastle.ac.uk
- Helen E BryantUniversity of SheffieldVerified email at sheffield.ac.uk
- John LunecNewcastle UniversityVerified email at ncl.ac.uk
- Ian HicksonCRUK Newcastle Drug Discovery Unit, Newcastle UniversityVerified email at newcastle.ac.uk
- Helen ReevesNewcastle UniversityVerified email at newcastle.ac.uk
- Mark MeuthVerified email at sheffield.ac.uk
- David JamiesonNewcastle UniversityVerified email at ncl.ac.uk
- Michele TavecchioSenior Scientist, NeuroVive Pharmaceutical SAVerified email at neurovive.com
- Johann de BonoInstitute of Cancer ResearchVerified email at icr.ac.uk
- Stephen JacksonUniversity of CambridgeVerified email at gurdon.cam.ac.uk
- Margaret BassendineVerified email at ncl.ac.uk
- Julie TuckerUniversity of YorkVerified email at york.ac.uk